Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats-Reference-Cited by-同舟云学术

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats

Published:2016-09-28 Issue: Volume:7 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Peres Fernanda F.,Levin Raquel,Suiama Mayra A.,Diana Mariana C.,Gouvêa Douglas A.,Almeida Valéria,Santos Camila M.,Lungato Lisandro,Zuardi Antônio W.,Hallak Jaime E. C.,Crippa José A.,Vânia D’Almeida,Silva Regina H.,Abílio Vanessa C.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference83 articles.

1. Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats.;Abilio;Prog. Neuropsychopharmacol. Biol. Psychiatry,2003a

2. Effects of melatonin on behavioral dopaminergic supersensitivity.;Abilio;Life Sci.,2003b

3. Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia.;Abilio;Neuropharmacology,2004

4. Effects of melatonin on orofacial movements in rats.;Abilio;Psychopharmacology (Berl),2002

5. Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test.;Almeida;Prog. Neuropsychopharmacol. Biol. Psychiatry,2013

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of p-cymene in amelioration of catalepsy Behavior, memory recovery and hippocampus cell damage in an animal model of Parkinson's disease;Medical Sciences Journal of Islamic Azad University;2024-06-01

2. Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson’s Rats;Pharmaceutics;2024-04-08

3. Cannabidiol Modulation of Nicotine-Induced Toxicity: Assessing Effects on Behavior, Brain-Derived Neurotrophic Factor, and Oxidative Stress in C57BL/6 Mice;2024-03-21

4. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders;Basic & Clinical Pharmacology & Toxicology;2024-03-13

5. Cannabidiol Modulation of Nicotine-Induced Toxicity: Assessing Effects on Behavior, Brain-Derived Neu-Rotrophic Factor, and Oxidative Stress C57BL/6 Mice;2024-03-06